From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
ASU’s Biodesign Institute will utilize Piper Trust support to increase its capacity for automated, rapid diagnostic testing to mitigate the viral spread and potential reoccurrence of COVID-19. “Now is the time for those who can — individuals and public- and private-sector organizations — to step in quickly and support our nonprofits,” said Mary Jane Rynd, […]
IMNA Solutions Provides TrialME, a Remote Patient Monitoring and Data Collection Platform to Support Drug Development and Keep Clinical Trials Open During COVID-19 Pandemic
Starting April 1st, 2020 through July 1st, 2020, IMNA is offering free access to the TrialME platform for all teams researching COVID-19 and other life debilitating diseases. TrialME offers sites a seamless shift to a hybrid structure that follows the FDA’s new guidelines during COVID-19 pandemic; the platform monitors, engages, and communicates with patients from […]
Amish Shah, MD is an emergency physician at Dignity Health and a member of the Arizona House of Representative elected by the people of LD24 – Central Phoenix and South Scottsdale. On Sunday, April 5, 2020, Dr. Shah shared the message below via Facebook. This Facebook post is republished with permission from Dr. Shah.
Dr. Patricia Beckmann is the Entrepreneurial Program Coordinator and Grant Administrator for AZBio supporting activities related to AZBio’s EDA Seed Fund Support Grant. Patricia’s overall career spans research, operations, law and venture capital.
- 1st Virtual Joint Meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board
- Biopreneur Business Brief
- FDA Webinar - Clinical Laboratory Improvement Amendments (CLIA) Waiver Applications Final Guidances
- Fllinn Arizona's Bioscience Roadmap Progress Event
- AZBioPEERS: Fundraising Tales From The Road - Webcast